AstraZeneca and the University of Oxford to Share Positive News on its COVID-19 Vaccine Imminently

Shots:

• As per ITV, AstraZeneca to share positive news on its AZD1222. The update could come tomorrow while the first data is due to be published in The Lancet
• According to Robert Peston, a UK journalist, the vaccine generating the kind of antibody and T-cell (killer cell) response that the researchers want. He revealed that not all vaccines under development across the globe increase both Abs and T-cells but the AZD1222 demonstrate twin effect
• The efficacy of the vaccine will be properly established in P-III program, which is underway in Brazil to deliver a large database assessing the safety as well as the efficacy of AZD1222. If approved, the company could go for mass production as early as Sept’20

Click here to read full press release/ article | Ref: ITV | Image: ITV

Related News: AstraZeneca Signs an Agreement with Symbiosis for Sterile Manufacturing of its AZD1222 Against COVID-19